Literature DB >> 24739604

Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm.

Takeshi Yamashita1, Masashi Yoshida, Hodaka Yamada, Tomoko Asano, Atsushi Aoki, Aki Ikoma, Ikuyo Kusaka, Masafumi Kakei, San-e Ishikawa.   

Abstract

A 78-year-old man with abdominal pain was diagnosed with a rupture of a gastric artery aneurysm. The serum Na level promptly decreased from 135 to 110 mmol/L within several days. Brain magnetic resonance angiography revealed severe vasoconstriction of the cerebral basilar artery and anterior cerebral artery. There was neither dehydration nor edema. The plasma arginine vasopressin level was 3.3 pg/mL, despite hypoosmolality. These findings indicated a diagnosis of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) derived from severe vasoconstriction of the cerebral arteries. The administration of 7.5 mg of tolvaptan rapidly increased the serum Na level from 123 to 138 mmol/L within the first 24 hours, thereafter continuously maintaining a normal level. Treatment with tolvaptan corrected the patient's dilutional hyponatremia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24739604     DOI: 10.2169/internalmedicine.53.1440

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

Review 1.  Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment.

Authors:  San-E Ishikawa
Journal:  J Clin Med       Date:  2017-10-31       Impact factor: 4.241

2.  Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Amyotrophic Lateral Sclerosis in a Patient Developing Carbon Dioxide Narcosis.

Authors:  Yui Inoue; Takaaki Murakami; Takeshi Nakamura; Kyohei Morita; Daita Kaneda; Ichizo Nishino; Tetsuya Hayashi; Yuya Shinoto; Tomonobu Hatoko; Tomoko Kato; Shin Yonemitsu; Seiji Muro; Shogo Oki
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.